Expert Opinion on Therapeutic Patents This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A patent review of MAPK inhibitors (2018 – present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 1, 2023 Category: Drugs & Pharmacology Authors: Valentin R Wydra Raphael B Ditzinger Nico J Seidler Frederik W Hacker Stefan A Laufer Source Type: research

Patent landscape highlighting therapeutic implications of peptides targeting myristoylated alanine-rich protein kinase-C substrate (MARCKS)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 1, 2023 Category: Drugs & Pharmacology Authors: Vikas Yadav Amarish Kumar Sharma Gaurav Parashar Nidarshana Chaturvedi Parashar Seema Ramniwas Manoj Kumar Jena Hardeep Singh Tuli Kiran Yadav Source Type: research

Proteolysis-Targeting Chimeras (PROTACs) targeting the BCR-ABL for the treatment of chronic myeloid leukemia – a patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 26, 2023 Category: Drugs & Pharmacology Authors: Andr é T. S. Vicente Jorge A.R. Salvador Source Type: research

A patent review of NLRP3 inhibitors to treat autoimmune diseases
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 26, 2023 Category: Drugs & Pharmacology Authors: Yiming Xu Savannah Biby Baljit Kaur Shijun Zhang Source Type: research

An updated patent review of Mcl-1 inhibitors (2020 –2022)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 14, 2023 Category: Drugs & Pharmacology Authors: Jingjing Liu Fangkui Yin Ziqian Wang Ting Song Zhichao Zhang Source Type: research

Pitfalls in patenting academic CAR-T cells therapy
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 6, 2023 Category: Drugs & Pharmacology Authors: C ătălin Constantinescu Roxana Constantinescu Jon Thor Bergthorsson Victor Greiff Alina Tanase Anca Colita Diana Gulei Ciprian Tomuleasa Source Type: research

An updated patent review of histone deacetylase (HDAC) inhibitors in cancer (2020 – present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 2, 2023 Category: Drugs & Pharmacology Authors: Yi-Min Liu Jing-Ping Liou Source Type: research

Vasopressin receptor antagonists: a patent summary (2018-2022)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 29, 2023 Category: Drugs & Pharmacology Authors: Ferenc Baska Éva Bozó Tam ás Patócs Source Type: research

An updated patent review of anaplastic lymphoma kinase inhibitors (2018 –2022)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 23, 2023 Category: Drugs & Pharmacology Authors: Deyi Ma Mengrao Guo Xin Zhai Source Type: research

A patent review of EZH2 inhibitors from 2017 and beyond
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 8, 2023 Category: Drugs & Pharmacology Authors: Guoquan Wan Huan Feng Chang Su Yongxia Zhu Lidan Zhang Qiangsheng Zhang Luoting Yu Source Type: research

A patent review of selective CDK9 inhibitors in treating cancer
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 5, 2023 Category: Drugs & Pharmacology Authors: Tizhi Wu Xiaowei Wu Yifan Xu Rui Chen Jubo Wang Zhiyu Li Jinlei Bian Source Type: research

Novel therapeutic opportunities for Toxoplasma gondii, Trichomonas vaginalis, and Giardia intestinalis infections
Volume 33, Issue 3, March 2023 . (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 4, 2023 Category: Drugs & Pharmacology Authors: Francesca Arrighi Arianna Granese Paola Chimenti Paolo Guglielmi Source Type: research

A patent review of PRMT5 inhibitors to treat cancer (2018 - present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 27, 2023 Category: Drugs & Pharmacology Authors: Jing Gao Jie Yang Shengyu Xue Hong Ding Hua Lin Cheng Luo Source Type: research

The management of Babesia, amoeba and other zoonotic diseases provoked by protozoa
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 24, 2023 Category: Drugs & Pharmacology Authors: Clemente Capasso Claudiu T. Supuran Source Type: research

Antimalarial drugs: what ’s new in the patents?
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 20, 2023 Category: Drugs & Pharmacology Authors: Elizabeth A. Lopes Maria M. M. Santos Mattia Mori Source Type: research